Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resting mononuclear cell NR3C1 and SKA2 expression levels predict blunted cortisol reactivity to combat training stress among elite army cadets exposed to childhood adversity.
Kalla C, Goltser-Dubner T, Pevzner D, Canetti L, Mirman A, Ben-Yehuda A, Itzhar N, Benarroch F, Shalev A, Giesser R, Fruchter E, Vashdi I, Oz O, Haber R, Saloner C, Lotan A, Galili-Weisstub E, Bonne O, Segman R. Kalla C, et al. Among authors: pevzner d. Mol Psychiatry. 2021 Nov;26(11):6680-6687. doi: 10.1038/s41380-021-01107-z. Epub 2021 May 12. Mol Psychiatry. 2021. PMID: 33981010
Elevated salivary uric acid levels among adolescents with eating disorders.
Giesser R, Goltser-Dubner T, Pevzner D, Shalev A, Masarwa R, Canetti L, Meltzer A, Qutna N, Ratson R, Kianski E, Keller S, Galili-Weisstub E, Segman R. Giesser R, et al. Among authors: pevzner d. Eat Weight Disord. 2020 Dec;25(6):1821-1825. doi: 10.1007/s40519-019-00799-1. Epub 2019 Oct 30. Eat Weight Disord. 2020. PMID: 31667778
Decreased mononuclear cell NR3C1 SKA2 and FKPB5 expression levels among adult survivors of suicide bombing terror attacks in childhood are associated with the development of PTSD.
Goltser-Dubner T, Shalev A, Benarroch F, Canetti L, Yogev M, Kalla C, Masarwa R, Martin J, Pevzner D, Oz O, Saloner C, Amer R, Lavon M, Lotan A, Galili-Weisstub E, Segman R. Goltser-Dubner T, et al. Among authors: pevzner d. Mol Psychiatry. 2023 Sep;28(9):3851-3855. doi: 10.1038/s41380-023-02278-7. Epub 2023 Oct 16. Mol Psychiatry. 2023. PMID: 37845495
Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study.
Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, Meray IA, Privalov DV, Taylor A, Grishin SA, Egorova AN, Ponomar EG, Lavrovsky Y, Samsonov MY. Abbate A, et al. Among authors: pevzner dv. J Cardiovasc Pharmacol. 2024 Dec 1;84(6):565-577. doi: 10.1097/FJC.0000000000001635. J Cardiovasc Pharmacol. 2024. PMID: 39642282 Free PMC article. Clinical Trial.
[Patient selection for left ventricular assist device implantation. The main problems].
Narusov OY, Shahramanova JA, Amanatova VA, Sychev AV, Osmolovskaya YF, Ganaev KG, Shiryaev AA, Merkulova IA, Pevzner DV, Makeev MI, Saidova MA, Paleev FN, Akchurin RS, Tereshchenko SN, Boytsov SA. Narusov OY, et al. Among authors: pevzner dv. Ter Arkh. 2024 Oct 10;96(9):885-891. doi: 10.26442/00403660.2024.09.202851. Ter Arkh. 2024. PMID: 39467243 Russian.
Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa study.
Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, Meray IA, Privalov DV, Taylor A, Grishin SA, Egorova AN, Ponomar EG, Lavrovsky Y, Samsonov MY. Abbate A, et al. Among authors: pevzner dv. J Cardiovasc Pharmacol. 2024 Oct 2. doi: 10.1097/FJC.0000000000001635. Online ahead of print. J Cardiovasc Pharmacol. 2024. PMID: 39357146
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, Meray I, Privalov DV, Taylor A, Grishin SA, Egorova AN, Ponomar EG, Lavrovsky Y, Samsonov MY; RPH-104 STEMI Study Investigators. Abbate A, et al. Among authors: pevzner dv. Circulation. 2024 Aug 13;150(7):580-582. doi: 10.1161/CIRCULATIONAHA.124.069396. Epub 2024 Aug 12. Circulation. 2024. PMID: 39133774 Clinical Trial. No abstract available.
55 results